Innovative Eyewear, Inc. (LUCY) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $7.06M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Harrison Reed Gross |
| IPO Date | 2022-08-15 | CAGR | 186.42% |
| Employees | 13 | Website | www.lucyd.co |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $4.97M | P/E | -0.66 | Forward P/E | — | PEG | — |
| P/S | 1.59 | P/B | 0.79 | P/CF | -0.75 | P/FCF | -0.73 |
| Sales | $3.41M | Sales 1Y | 72.5% | Sales 3Y | 539.1% | Sales 5Y | 1104.8% |
| EPS | $-1.69 | EPS 1Y | -58.33% | EPS 3Y | -91.63% | EPS 5Y | -73.27% |
| Sales QoQ | 30.63% | EPS QoQ | -29.73% | Sales QoQ Avg | 17.56% | EPS QoQ Avg | -18.46% |
| Gross Margin | 22.79% | Operating Margin | -249.03% | Profit Margin | -225.28% | ROCE | -122.96% |
| ROA | -103% | ROE | -89% | Altman Z Score | -0.63 | Piotroski Score | 3 |
| Current Ratio | 12.06 | Quick Ratio | 11.25 | Cash Ratio | 4.36 | Op. CF Ratio | -3.31 |
| Debt/Equity | — | Debt/Assets | — | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | 5.77 | Asset Turnover | 0.46 | Receivables Turnover | 25.01 |
| Enterprise Value | $4.97M | P/E Ratio | -0.66 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.59 | P/B Ratio | 0.79 |
| P/CF Ratio | -0.75 | P/FCF Ratio | -0.73 |
| EPS | $-1.69 | EPS Growth 1Y | -58.33% |
| EPS Growth 3Y | -91.63% | EPS Growth 5Y | -73.27% |
| Revenue Growth 1Y | 72.5% | Gross Margin | 0.23% |
| Operating Margin | -2.49% | Profit Margin | -2.25% |
| ROE | -0.89% | ROA | -1.03% |
| ROCE | -1.23% | Current Ratio | 12.06 |
| Quick Ratio | 11.25 | Cash Ratio | 4.36 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | -0.63 | Piotroski Score | 3 |
Innovative Eyewear, Inc. (LUCY) valuation & financials
Innovative Eyewear, Inc. (LUCY) has a market capitalization of $7.06M and trades at a price-to-earnings ratio of -0.7. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Innovative Eyewear, Inc.'s revenue grew +72.5% over the last year.
Innovative Eyewear, Inc.'s next earnings report is scheduled for November 12, 2026; analysts estimate EPS of $-0.35. Check the earnings calendar to see all companies reporting this week.
Innovative Eyewear, Inc. (LUCY) — frequently asked questions
When does Innovative Eyewear, Inc. (LUCY) report earnings next?
Innovative Eyewear, Inc. is expected to report earnings on November 12, 2026. Analysts estimate EPS of $-0.35.
What is Innovative Eyewear, Inc.'s market cap?
Innovative Eyewear, Inc. (LUCY) has a market capitalization of $7.06M.
What is LUCY's P/E ratio?
Innovative Eyewear, Inc. trades at a price-to-earnings ratio of -0.7, with trailing twelve-month EPS of $-1.69.
How fast is Innovative Eyewear, Inc. growing?
Innovative Eyewear, Inc.'s revenue grew +72.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)